WORG AT A GLANCE


Worg is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases with high unmet medical needs and considerable commercial potential.

Headquartered in Hangzhou at the heart of one of China's biotech hubs, Worg was founded in 2018 and led by an executive team from China, the United States and Europe who have extensive experience in life science executive, pharmaceutical development, clinical trials, regulatory affairs and commercialization.

Worg plans to build the pipeline of allergy and other therapeutical indications through internal development and external partnering with flexible options.

MISSION AND VISION

MISSION

To become a respected biopharmaceutical company through accelerated product development to benefit patients in need.

VISION

WE CARE  we care about patients and focus on their medical needs.
WE DELIVER  we deliver new treatments to patients and create value for our partners.

LEADERSHIP

Andrew Xu

PhD, Founder, Chairman and CEO


Rainer Henning

PhD, Chief Scientific Officer


Charles Richard Jones

DM, MRCP, Chief Medical Officer


Howard Yuwen

PhD, Chief Compliance Officer
Co-founder

SCIENTIFIC ADVISORY BOARD

Rudolf Valenta

Special Advisor

Adam Cohen

Scientific Advisory Board

Adnan Custovic

Scientific Advisory Board

Dong-yan Jin

Scientific Advisory Board

Margitta Worm

Scientific Advisory Board

CAREERS

Worg is looking for the professionals with similar values, entrepreneurial spirit and willingness to contribute. We provide broad career channels, competitive salary, harmonious and friendly working atmosphere and abundant training opportunities.